Sort   by:  
 Page size 
UnknownProtocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry.
Not available
S-EPMC10630783 | biostudies-literature
UnknownTargeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.
Not available
S-EPMC10992601 | biostudies-literature
UnknownPrecision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Not available
S-EPMC7418426 | biostudies-literature
UnknownOptimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Not available
S-EPMC6593525 | biostudies-literature
UnknownSafety and efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial.
Not available
S-EPMC11739593 | biostudies-literature
UnknownA phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Not available
S-EPMC10633948 | biostudies-literature
UnknownBaseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma.
Not available
S-EPMC7352427 | biostudies-literature
UnknownLow incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.
Not available
S-EPMC7445552 | biostudies-literature
Sort   by:  
 Page size